5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-line nivolumab plus ipilimumab versus sunitinib in patients without nephrectomy and with an evaluable primary renal tumor in the CheckMate 214 trial
    Journal Article

    Albiges, L.; Tannir, N. M.; Burotto, M.; McDermott, D.; Plimack, E. R.; Barthélémy, P.; Porta, C.; Powles, T.; Donskov, F.; George, S.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing
    Journal Article

    Terraf, P.; Pareja, F.; Brown, D. N.; Ceyhan-Birsoy, O.; Misyura, M.; Rana, S.; O'Reilly, E.; Carlo, M. I.; Aghajanian, C.; Liu, Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality
    Journal Article

    Keegan, N. M.; Vasselman, S. E.; Barnett, E. S.; Nweji, B.; Carbone, E. A.; Blum, A.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; more...
    Prostate (2022)

    Fulltext@MSK | Save
  • Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity
    Journal Article

    Mazzu, Y. Z.; Liao, Y.; Nandakumar, S.; Sjöström, M.; Jehane, L. E.; Ghale, R.; Govindarajan, B.; Gerke, T. A.; Lee, G. S. M.; Luo, J. H.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • Management of patients with advanced prostate cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
    Review

    Gillessen, S.; Armstrong, A.; Attard, G.; Beer, T. M.; Beltran, H.; Bjartell, A.; Bossi, A.; Briganti, A.; Bristow, R. G.; Bulbul, M.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • What experts think about prostate cancer management during the COVID-19 pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
    Editorial

    Turco, F.; Armstrong, A.; Attard, G.; Beer, T. M.; Beltran, H.; Bjartell, A.; Bossi, A.; Briganti, A.; Bristow, R. G.; Bulbul, M.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302
    Journal Article

    Wilson, B. E.; Armstrong, A. J.; de Bono, J.; Sternberg, C. N.; Ryan, C. J.; Scher, H. I.; Smith, M. R.; Rathkopf, D.; Logothetis, C. J.; Chi, K. N.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
    Journal Article

    Korsen, J. A.; Gutierrez, J. A.; Tully, K. M.; Carter, L. M.; Samuels, Z. V.; Khitrov, S.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): Long-term follow-up results from an open-label, randomised, phase 3 trial
    Journal Article

    Motzer, R. J.; Powles, T.; Burotto, M.; Escudier, B.; Bourlon, M. T.; Shah, A. Y.; Suárez, C.; Hamzaj, A.; Porta, C.; Hocking, C. M.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Association of family history of cancer with clinical and pathological outcomes for prostate cancer patients on active surveillance
    Journal Article

    Jibara, G. A.; Perera, M.; Vertosick, E. A.; Sjoberg, D. D.; Vickers, A.; Scardino, P. T.; Eastham, J. A.; Laudone, V. P.; Touijer, K.; Lin, X.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save